Tarlatamab for extensive-stage small-cell lung cancer after 2 or more treatments

Tarlatamab (Imdylltra) is not normally available on the NHS for treating extensive-stage small-cell lung cancer in adults whose cancer has got worse after 2 or more lines of treatment, including platinum-based chemotherapy.

Lines of treatment are a sequence of treatments, starting with the most suitable option and moving to alternatives if the first does not work or the condition gets worse. Each line can be a single drug or a combination of drugs.

Your healthcare professional should talk with you about other treatment options. If you are already having it, you should be able to continue until you and your healthcare professional decide when best to stop.

Information and support

The NHS webpage on lung cancer may be a good place to find out more.

These organisations can give you advice and support:

• Roy Castle Lung Cancer Foundation, 0333 323 7200
• Lung Cancer Nursing UK (LCNUK), 01675 477607
• Cancer Research UK, 0808 800 4040
• Macmillan Cancer Support, 0808 808 0000

You can also get support from your local Healthwatch.

NICE is not responsible for the quality or accuracy of any information or advice provided by these organisations.

ISBN: 978-1-4731-7147-3